Feeder layer-free in vitro assay for screening antitrypanosomal compounds against Trypanosoma brucei brucei and T. b. evansi

A drug-susceptible Trypanosoma brucei brucei stock, a multidrug-resistant T. b. brucei stock, and a T. b. evansi stock resistant to two commercial trypanocides were adapted to a feeder layer-free culture system. Bloodstream forms were grown continuously in a liquid medium at 37 degrees C in 4% CO2 i...

Full description

Bibliographic Details
Main Authors: Kaminsky, R., Zweygarth, E.
Format: Journal Article
Language:Inglés
Published: American Society for Microbiology 1989
Subjects:
Online Access:https://hdl.handle.net/10568/30082
_version_ 1855528340830552064
author Kaminsky, R.
Zweygarth, E.
author_browse Kaminsky, R.
Zweygarth, E.
author_facet Kaminsky, R.
Zweygarth, E.
author_sort Kaminsky, R.
collection Repository of Agricultural Research Outputs (CGSpace)
description A drug-susceptible Trypanosoma brucei brucei stock, a multidrug-resistant T. b. brucei stock, and a T. b. evansi stock resistant to two commercial trypanocides were adapted to a feeder layer-free culture system. Bloodstream forms were grown continuously in a liquid medium at 37 degrees C in 4% CO2 in air. Samples of trypanosome populations in the logarithmic growth phase were incubated with various concentrations of commercial and experimental compounds. Growth inhibition was monitored after a 24-h incubation and quantified by comparing the number of generations between control and drug-treated cultures. Some of the experimental compounds [taxol, formicin B, thioridazine, Ro 15-0216, and DL-alpha-(difluoromethyl)ornithine hydrochloride monohydrate] showed activity against both drug-susceptible and drug-resistant trypanosomes. Other compounds [sinefungin, 1,3,5-triacetylbenzene tris(guanylhydrazone)trimethanesulfonate hydrate, and 9-deazainosine] which inhibited the growth of drug-susceptible trypanosomes showed little or no effect upon drug-resistant parasites. Gossypol, however, had no antitrypanosomal effect on either trypanosome stock. The results obtained in this study correlate with observations obtained from drug screening in mice. The main advantages of the described in vitro screening assay are as follows: (i) lower amounts of drugs are required, (ii) results are obtained more rapidly, (iii) animals are not necessary, and (iv) the method is less labor intensive. These advantages result in an economical and rapid assay for primary drug screening.
format Journal Article
id CGSpace30082
institution CGIAR Consortium
language Inglés
publishDate 1989
publishDateRange 1989
publishDateSort 1989
publisher American Society for Microbiology
publisherStr American Society for Microbiology
record_format dspace
spelling CGSpace300822024-05-01T08:17:52Z Feeder layer-free in vitro assay for screening antitrypanosomal compounds against Trypanosoma brucei brucei and T. b. evansi Kaminsky, R. Zweygarth, E. trypanosoma brucei trypanosoma evansi disease control animal diseases A drug-susceptible Trypanosoma brucei brucei stock, a multidrug-resistant T. b. brucei stock, and a T. b. evansi stock resistant to two commercial trypanocides were adapted to a feeder layer-free culture system. Bloodstream forms were grown continuously in a liquid medium at 37 degrees C in 4% CO2 in air. Samples of trypanosome populations in the logarithmic growth phase were incubated with various concentrations of commercial and experimental compounds. Growth inhibition was monitored after a 24-h incubation and quantified by comparing the number of generations between control and drug-treated cultures. Some of the experimental compounds [taxol, formicin B, thioridazine, Ro 15-0216, and DL-alpha-(difluoromethyl)ornithine hydrochloride monohydrate] showed activity against both drug-susceptible and drug-resistant trypanosomes. Other compounds [sinefungin, 1,3,5-triacetylbenzene tris(guanylhydrazone)trimethanesulfonate hydrate, and 9-deazainosine] which inhibited the growth of drug-susceptible trypanosomes showed little or no effect upon drug-resistant parasites. Gossypol, however, had no antitrypanosomal effect on either trypanosome stock. The results obtained in this study correlate with observations obtained from drug screening in mice. The main advantages of the described in vitro screening assay are as follows: (i) lower amounts of drugs are required, (ii) results are obtained more rapidly, (iii) animals are not necessary, and (iv) the method is less labor intensive. These advantages result in an economical and rapid assay for primary drug screening. 1989-06 2013-06-11T09:26:09Z 2013-06-11T09:26:09Z Journal Article https://hdl.handle.net/10568/30082 en Open Access American Society for Microbiology Antimicrobial Agents and Chemotherapy;33: 881-885
spellingShingle trypanosoma brucei
trypanosoma evansi
disease control
animal diseases
Kaminsky, R.
Zweygarth, E.
Feeder layer-free in vitro assay for screening antitrypanosomal compounds against Trypanosoma brucei brucei and T. b. evansi
title Feeder layer-free in vitro assay for screening antitrypanosomal compounds against Trypanosoma brucei brucei and T. b. evansi
title_full Feeder layer-free in vitro assay for screening antitrypanosomal compounds against Trypanosoma brucei brucei and T. b. evansi
title_fullStr Feeder layer-free in vitro assay for screening antitrypanosomal compounds against Trypanosoma brucei brucei and T. b. evansi
title_full_unstemmed Feeder layer-free in vitro assay for screening antitrypanosomal compounds against Trypanosoma brucei brucei and T. b. evansi
title_short Feeder layer-free in vitro assay for screening antitrypanosomal compounds against Trypanosoma brucei brucei and T. b. evansi
title_sort feeder layer free in vitro assay for screening antitrypanosomal compounds against trypanosoma brucei brucei and t b evansi
topic trypanosoma brucei
trypanosoma evansi
disease control
animal diseases
url https://hdl.handle.net/10568/30082
work_keys_str_mv AT kaminskyr feederlayerfreeinvitroassayforscreeningantitrypanosomalcompoundsagainsttrypanosomabruceibruceiandtbevansi
AT zweygarthe feederlayerfreeinvitroassayforscreeningantitrypanosomalcompoundsagainsttrypanosomabruceibruceiandtbevansi